Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2003
11/27/2003WO2003097805A2 Delivery of nucleic acid-like compounds
11/27/2003WO2003097714A1 Fat binding using inter-polymer complex of glucosamine and polyacrylic acid
11/27/2003WO2003097699A1 Immobilization of glycoproteins
11/27/2003WO2003097672A1 Method for controlling protein
11/27/2003WO2003097663A2 Immunogenic, monoclonal antibody comprising at least 2 different epitopes of a tumor-associated antigen
11/27/2003WO2003097647A1 Vitamin-mitomycin conjugates
11/27/2003WO2003097625A1 Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
11/27/2003WO2003097356A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003WO2003097140A1 Drug delivery assembly
11/27/2003WO2003097109A1 Improvements in delivery technology
11/27/2003WO2003097107A2 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
11/27/2003WO2003097106A2 Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent
11/27/2003WO2003097105A1 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent (s)
11/27/2003WO2003097102A1 Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water
11/27/2003WO2003097101A1 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
11/27/2003WO2003097083A1 Medicinal compositions containing ghrelin
11/27/2003WO2003097080A1 A stable aqueous composition of a peptide
11/27/2003WO2003097058A1 New pharmaceutical compositions containing flibanserin polymorph a
11/27/2003WO2003097054A1 Compositions and method for treating infection in cattle and swine
11/27/2003WO2003097039A1 Stable dosage forms comprising atorvastatin calcium
11/27/2003WO2003097022A1 Matrix type patch containing bronchodilators
11/27/2003WO2003097017A1 Use of completely linear short chain alpha-glucans as a pharmaceutical excipient
11/27/2003WO2003097015A1 Short chain polymer for enhancing the bioadhesiveness of polymers on mucosal membrane
11/27/2003WO2003097012A1 Co-grinding process for the preparation of a ternary composition
11/27/2003WO2003097010A1 Medicinal preparation in a colloid for topical application in the therapy and prophylaxis of states of pain and itching
11/27/2003WO2003097009A1 Injection formulation
11/27/2003WO2003096991A2 Amelioration of the development of cataracts and other opthalmic diseases
11/27/2003WO2003096983A2 Method of treating dyslipidemic disorders
11/27/2003WO2003096975A2 Pharmaceutical compositions and methods of using c-21 modified epothilone derivatives
11/27/2003WO2003096973A2 A direct cellular energy delivery system
11/27/2003WO2003096963A1 Powder compaction and enrobing
11/27/2003WO2003096944A1 Methods and formulations for the delivery of pharmacologically active agents
11/27/2003WO2003096782A2 Process for preparing maytansinol
11/27/2003WO2003067209A3 Ligands to enhance cellular uptake of biomolecules
11/27/2003WO2003061636A3 Dna dosage forms
11/27/2003WO2003059942A9 Peptides and peptidomimetics having anti-proliferative activity and their use
11/27/2003WO2003059382A3 Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression
11/27/2003WO2003057837A3 Methods for using anti-muc18 antibodies
11/27/2003WO2003053336A3 Methods for the treatment of peripheral neural and vascular ailments
11/27/2003WO2003042344A3 Apo2 ligand/trail formulations
11/27/2003WO2003041651A3 Allatoin-containing skin cream
11/27/2003WO2003032964A3 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
11/27/2003WO2003028656A3 Adjuvant compositions
11/27/2003WO2003020235A3 Stabilisation of oxidation-sensitive and uv-sensitive active ingredients
11/27/2003WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes
11/27/2003WO2003011207A3 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine
11/27/2003WO2003009817A3 Stable lyophilized pharmaceutical formulation of igg antibodies
11/27/2003WO2003009802A3 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2003007881A3 Antibodies specific for nanotubes and related methods and compositions
11/27/2003WO2002078730A3 Use of neublastin polypeptides for treating neuropathic pain
11/27/2003WO2002072095A3 Tiotropium salts for treating inflammatory diseases
11/27/2003WO2002070014A8 Compositions comprising an o/w emulsion containing conjugated linoleic acid
11/27/2003WO2002067903A3 Compositions and methods of manufacture for oral dissolvable dosage forms
11/27/2003WO2002063010A3 Method of producing recombinant antibodies against tumors
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002060385A3 Pharmaceutical formulation
11/27/2003WO2002056896A3 Treatment solution in addition to dressing material for caring for wounds
11/27/2003WO2001078727A8 Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia
11/27/2003WO2000050046A8 Stabilized oral pharmaceutical composition containing iodide and iodate and method
11/27/2003US20030221201 Comprises chimeric transferrin-glucogon like polypeptide with reduced glycosylation, metal binding and receptor recognition for treatment and prevntion of multiple sclerosis, cancer and viral diseases
11/27/2003US20030220490 Cell membrane directed drugs
11/27/2003US20030220474 Conjugate of biodegradable aliphatic polyester with Tat49-57 peptide or peptide chain containing Tat49-57 peptide and nanoparticle manufactured using the same
11/27/2003US20030220468 Modified forms of pharmacologically active agents and uses therefor
11/27/2003US20030220447 Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution
11/27/2003US20030220413 Coating and binding agent for oral or dermal pharmaceutical forms
11/27/2003US20030220406 Solubilizers containing mixtures of ethylene oxide-fatty alcohol, ethylene oxide-propylene oxide fatty alcohol and ethylene oxide-fatty acid adducts, used as solutes for cosmetics and drugs
11/27/2003US20030220378 Oral administration of epothilones
11/27/2003US20030220311 Programmable genotoxic agents and uses therefor
11/27/2003US20030220302 Combination of flunixin or the meglumine salt with a fluorinated chloramphenicol or thiamphenicol derivative antibiotic such as florfenicol
11/27/2003US20030220301 Metformin salts of lipophilic acids
11/27/2003US20030220298 Combrestatin a-1 phosphate and combrestatin b-1 phosphate prodrugs
11/27/2003US20030220292 Treatment of erectile dysfunction
11/27/2003US20030220274 Plasmid comprising a chicken beta actin promoter and enhancer; a modified GLP-1 (7-37) cDNA (p beta GLP1), carrying a furin cleavage site
11/27/2003US20030220270 Mono-and disaccharide derivatives
11/27/2003US20030220264 Reversible modification of membrane interaction
11/27/2003US20030220254 Composition and method for preparation of an oral dual controlled release formulation of a protein and inhibitor
11/27/2003US20030220245 Conjugate addition reactions for the controlled delivery of pharmaceutical active compounds
11/27/2003US20030220237 Pharmaceutical composition
11/27/2003US20030220233 Radiolabeled annexins
11/27/2003US20030220226 Compounds and compositions for delivering active agents
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219826 Comprises amino acid sequence for treating arthritic, inflammatory and apoptosis disorders; mimetics
11/27/2003US20030219514 Casing of a gelatin-free, water- based, set hydrocolloid gel that forms an enclosure, and at least one solid, liquid, soft or particulate center enclosed by the casing
11/27/2003US20030219497 Methods of treating ileus
11/27/2003US20030219490 Nanoparticulate megestrol formulations
11/27/2003US20030219489 Solid pharmaceutical dispersions with enhanced bioavailability
11/27/2003US20030219486 Crosslinking agent reacts with reactive pendant groups existing on the keratin molecules to produce biocompatible heterogenous proteinaceous networks crosslinked with the heterogenous crosslinker
11/27/2003US20030219484 A dosage form containing at least one active ingredient, which comprises a core and a shell with one or more openings, and readily soluble in gastrointestinal fluid, surrounding the core
11/27/2003US20030219481 A controlled release dosage form for oral administration containing aglipizide or salt, a controlled release matrix cotaining gelling agent, an ionizable gel strength enhcancer and an inert diluent
11/27/2003US20030219478 The filling of a pullulan based capsule including an aldehyde group in the molecule, or a precursor
11/27/2003US20030219476 Administering to a mammal a pharmaceutical formulation containing mitoxantrone in a cardiolipin (a liposome), and a excipient to treat cancer and multiple sclerosis
11/27/2003US20030219475 Preservation of bioactive materials by freeze dried foam
11/27/2003US20030219473 A lipid based cochelate formed of a purified soy- based phospholipid such as soy phosphatidylserine, and a multivalent cation selected from calcium, magnesium and zinc
11/27/2003US20030219472 Compositions and method for transmucosal drug delivery and cryoprotection
11/27/2003US20030219465 Composition for delivery of dithranol
11/27/2003US20030219461 Treating inflammation by administering antibiotics (penicillin) and cyclooxygenase-2 inhibitor (celecoxib)
11/27/2003US20030219459 Fusion proteins; epitopes; microarrays; vaccines
11/27/2003US20030219445 Reagents for cell selection and methods of use
11/27/2003US20030219441 Combined methods and compositions for coagulation and tumor treatment
1 ... 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 ... 1712